Benitec Biopharma Inc. ( BNTC) - Stock Earnings
BNTC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -9.0 million USD | — USD |
| 2025Q4 | -11.8 million USD | — USD |
| 2026Q1 | -11.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BNTC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -19.6 million USD | 75000 USD |
| 2024 | -21.8 million USD | 216000 USD |
| 2025 | -37.9 million USD | — USD |
| 2026 Est. | — | — |
BNTC
Price: $11.10
52 week price:
Earnings Per Share: -0.93 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208500
Ebitda: -11.8 millionMarket Capitalization: 290.0 million